Filipe Moura

Assistant Professor

Yale University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Filipe Moura is an Assistant Professor at Yale University, USA. His research focuses on the genetic and proteomic factors associated with type 2 diabetes and its comorbidities, cardiovascular health, and the efficacy of therapies for metabolic disorders. Recent articles by Professor Moura explore topics such as plasma proteomic markers, coronary microvascular dysfunction, and innovative approaches to assess valve regurgitation severity.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (13)

Laura Rasmussen-Torvik

Associate Professor and Chief of Epidemiology

Northwestern University Feinberg School of Medicine

UNITED STATES

View details

Mark Pereira

University of Minnesota

UNITED STATES

View details

Aude Deydier

Institut Pasteur de Lille

FRANCE

View details

Ruth Loos

Københavns Universitet

DENMARK

View details

Jennifer Ann Smith

Research Associate Professor

University of Michigan

UNITED STATES

View details

Tiinamaija Tuomi

University of Helsinki

FINLAND

View details

Charles Burant

University of Michigan

UNITED STATES

View details

Eric Sijbrands

Erasmus University Rotterdam

NETHERLANDS

View details

Stavroula Kanoni

Reader (Associate Professor) in Nutrigenetics and Cardiovascular Health

Queen Mary University of London

UNITED KINGDOM

View details

Josh Denny

National Institutes of Health

UNITED STATES

View details

Xiang Li

Assistant Professor

Harvard Medical School

UNITED STATES

View details

Niels Grarup

Københavns Universitet

DENMARK

View details

Andrew Morris

The University of Manchester

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Filipe Moura

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities

Type 2 diabetes genetic risk and incident diabetes across diabetes risk enhancers

Skeletal muscle adiposity, coronary microvascular dysfunction, and adverse cardiovascular outcomes

A Bayesian Interpretation of CABANA and Other Randomized Controlled Trials for Catheter Ablation in Patients With Atrial Fibrillation

Genetic drivers of heterogeneity in type 2 diabetes pathophysiology

Risk of new‐onset diabetes and efficacy of pharmacological weight loss therapy

Assessment of valve regurgitation severity via contrastive learning and multi-view video integration

Body Composition, Coronary Microvascular Dysfunction, and Future Risk of Cardiovascular Events Including Heart Failure

Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk

Diacerein reduces inflammasome activation and SARS-CoV-2 virus replication: a proof-of-concept translational study

Assessment of Atherothrombotic Risk in Patients With Type 2 Diabetes Mellitus

Comparative effectiveness and cost-effectiveness of cardioprotective glucose-lowering therapies for type 2 diabetes in Brazil: a Bayesian network model

Efficacy and safety of the dual GIP and GLP-1 receptor agonist tirzepatide for weight loss: a meta-analysis of randomized controlled trials

Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes

Evolocumab on top of empagliflozin improves endothelial function of individuals with diabetes: randomized active-controlled trial.

Collaborators (13)

Laura Rasmussen-Torvik

Mark Pereira

Aude Deydier

Ruth Loos

Jennifer Ann Smith

Tiinamaija Tuomi

Charles Burant

Eric Sijbrands

Stavroula Kanoni

Josh Denny

Xiang Li

Niels Grarup

Andrew Morris

Make your next move.